Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
European Heart Failure Guideline Updates: A Peer-to-Peer Discussion on SGLT-2 Inhibitors
Author(s): Andrew JS Coats , Carolyn Lam Added: 2 years ago
SGLT-2 inhibitors represent one of the single biggest advances in heart failure practice. In the anticipated HF Guidelines, join Prof Andrew Coats and Prof Carolyn Lam in this peer-to-peer video, where we get a local interpretation and take a look back at the 2016 guidelines first and the move onto the 2021 ESC heart failure guideline updates and what this means for the use of SGLT-2 inhibitors… View more

Standards & Guidelines

Heart Failure
ESC 2019: A review of SGLT2 inhibitors in HF - Prof Marc Sabatine & Prof Lars Kober
Author(s): Marc S Sabatine , Lars Kober Added: 4 years ago
Mark Sabatine & Lars Kober analyse the latest SGLT2 data presented at ESC 2019 View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Davide Stolfo , Gianluigi Savarese Added: 5 years ago
Heart failure (HF) is a major and growing public health problem with high morbidity, mortality and costs.1 Due to the ageing the population, the mean age of patients with HF is increasing and exceeds 70 years in most developed countries. HF prevalence rises with age and exceeds 10% in people over 80.2 Older patients are more frail and have a higher risk of cardiovascular events. They also have a… View more

Heart Failure
ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes
Author(s): Javed Butler , Stefan Anker Added: 5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker Filmed on-site at ESC 2018 by Radcliffe Cardiology. View more

Prevention & Chronic Conditions
Heart Failure in Focus Podcast - Ep 2
Author(s): Muthiah Vaduganathan , Carolyn Lam Added: 1 year ago
Join us for our second podcast in the series where our host Dr Muthiah Vaduganathan continues the theme of SGLT-2 inhibitors in heart failure. This month’s guest is Prof Carolyn Lam who, together with Muthu, will be answering your questions about SGLT-2 inhibitors and the practical management of heart failure patients.All of the questions answered in this podcast have been submitted by real… View more

Heart Failure
Author(s): Ovidiu Chioncel , Sean P Collins , Andrew P Ambrosy , et al Added: 3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches. Pulmonary oedema (PO) is a common manifestation of AHF associated with a… View more

Heart Failure
Author(s): Yury Lopatin Added: 3 years ago
Heart failure is currently one of the leading causes of death and disability worldwide, which makes it a major public health problem.1,2 Traditionally, heart failure is considered a complex syndrome with several features, including abnormal myocardial function and excessive, continuous neurohumoral activation. In this context, the current optimal pharmacological treatment of heart failure focuses… View more

Heart Failure
Author(s): Gabriele Fragasso Added: 3 years ago
The development of heart failure is rarely dependent on primary alterations of cardiac metabolism. The majority of heart failure cases result from diseases of the cardiac muscle, most frequently ischaemic heart disease. However, whatever the cause of heart failure, the net result will be depletion of myocardial adenosine triphosphate (ATP), phosphocreatine and creatine kinase levels with… View more

Heart Failure
Author(s): Patrick Campbell , Selim Krim , Hector Ventura Added: 3 years ago
Heart failure remains a significant burden to the US healthcare system and contributes greatly to the morbidity and mortality of the population. The impact of an ageing population, improved survival in coronary artery disease (CAD) and adverse life-style choices will ultimately result in an increased burden on an already taxed health care system. Heart failure affects over 5 million people with… View more

Heart Failure

Prevention & Chronic Conditions
Hyperkalaemia in Heart Failure
Author(s): Umar Ismail , Kiran Sidhu , Shelley Zieroth Added: 2 years ago

Heart Failure